Clinical Trial Update: An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

This report notes the completion of an open-label Phase 2 pilot trial evaluating Coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Muscular Dystrophy, Duchenne | Phase 2 | Status: COMPLETED